Cargando…
Use of real-world evidence in economic assessments of pharmaceuticals in the United States
BACKGROUND: Despite the increasing interest in expanding the use of real-world evidence (RWE) in economic assessments of pharmaceuticals, decision makers face uncertainty about how RWE should be used. OBJECTIVE: To assess the use of RWE in economic assessments of drugs by the Institute for Clinical...
Autores principales: | Lee, Woojung, Dayer, Victoria, Jiao, Boshen, Carlson, Josh J, Devine, Beth, Veenstra, David L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390921/ https://www.ncbi.nlm.nih.gov/pubmed/33377439 http://dx.doi.org/10.18553/jmcp.2021.27.1.005 |
Ejemplares similares
-
The use of real-world evidence in ICER’s scoping process and clinical evidence assessments
por: Jiao, Boshen, et al.
Publicado: (2020) -
Real-world evidence for option value in metastatic melanoma
por: Wong, William B, et al.
Publicado: (2021) -
Online tools to synthesize real-world evidence of comparative effectiveness research to enhance formulary decision making
por: Chen, Shuxian, et al.
Publicado: (2021) -
Real-world treatment patterns and economic burden of post-cataract macular edema
por: Ahmadyar, Gina, et al.
Publicado: (2023) -
Real-World Evaluation of Direct and Indirect Economic Burden Among Endometriosis Patients in the United States
por: Soliman, Ahmed M., et al.
Publicado: (2018)